Evaluating the toxicity of the analgesic glutaminase inhibitor 6-diazo-5-oxo -l-norleucine in vitro and on rat dermal skin fibroblasts - MedCrave online
6-Diazo-5-oxo-L-norleucine - Chem-Impex International
l-asparaginase and 6-diazo-5-oxo-l-norleucine synergistically inhibit the growth of glioblastoma cells | SpringerLink
Nitroferroin - TOKU-E
6-Diazo-5-oxo-L-norleucine | S8620-GRP | Universal Biologicals
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs. - Abstract - Europe PMC
6-Diazo-5-oxo-L-norleucine for Sale from Quality Suppliers - ECHEMI
FD49029 | 157-03-9 | 6-Diazo-5-oxo-L-norleucine
6-Diazo-5-oxo-L-norleucine | ≥99%(HPLC) | Selleck | Glutaminase 阻害剤
6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine) | Glutaminases Antagonist | MedChemExpress
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
Structure of 6-diazo-5-oxo-norleucine-bound human gamma-glutamyl transpeptidase 1, a novel mechanism of inactivation
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
6-Diazo-5-oxo-L-norleucine | C6H9N3O3 | ChemSpider
Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry
6-Diazo-5-oxo-L-norleucine | CAS 157-03-9 | SCBT - Santa Cruz Biotechnology
File:6-diazo-5-oxo-L-norleucine.png - Wikimedia Commons
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect
6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug | Science Advances
